AXT (AXTI)
(Delayed Data from NSDQ)
$2.62 USD
+0.23 (9.62%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $2.62 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$2.62 USD
+0.23 (9.62%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $2.62 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Zacks News
AXT (AXTI) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
AXT (AXTI) delivered earnings and revenue surprises of 33.33% and 7.71%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
AXT (AXTI) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
AXT (AXTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why AXT (AXTI) Might be Well Poised for a Surge
by Zacks Equity Research
AXT (AXTI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
AXT (AXTI) Is Up 32.81% in One Week: What You Should Know
by Zacks Equity Research
Does AXT (AXTI) have what it takes to be a top stock pick for momentum investors? Let's find out.
The Zacks Analyst Blog Highlights: Pfizer, AXT, Glu Mobile and iClick Interactive
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Pfizer, AXT, Glu Mobile and iClick Interactive
3 Cheap Tech Stocks Under $10 to Buy on Bullish Vaccine Outlook
by Benjamin Rains
Let's dive into three tech stocks that are trading for under $10 per share that investors might want to buy amid broader bullish vaccine sentiment in the market...
Earnings Estimates Moving Higher for AXT (AXTI): Time to Buy?
by Zacks Equity Research
AXT (AXTI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
AXT (AXTI) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
AXT (AXTI) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Are You Looking for a Top Momentum Pick? Why AXT (AXTI) is a Great Choice
by Zacks Equity Research
Does AXT (AXTI) have what it takes to be a top stock pick for momentum investors? Let's find out.
AXT (AXTI) Reports Next Week: What to Expect
by Zacks Equity Research
AXT (AXTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AXT (AXTI) Looks Good: Stock Adds 9.8% in Session
by Zacks Equity Research
AXT (AXTI) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
Zacks.com featured highlights include: NetEase, USA Truck, AXT and Moderna
by Zacks Equity Research
Zacks.com featured highlights include: NetEase, USA Truck, AXT and Moderna
4 Stocks With Solid Earnings Acceleration to Watch
by Tirthankar Chakraborty
If the rate of a company's quarter-over-quarter earnings growth increases within a stipulated frame of time, it can be called earnings acceleration.
AXT (AXTI) Jumps: Stock Rises 7.3%
by Zacks Equity Research
AXT (AXTI) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
AXT (AXTI) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
AXT (AXTI) delivered earnings and revenue surprises of 200.00% and 1.81%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: AXT (AXTI) Q2 Earnings Expected to Decline
by Zacks Equity Research
AXT (AXTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What Makes AXT (AXTI) a New Buy Stock
by Zacks Equity Research
AXT (AXTI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Electronics Semiconductors Industry Boasts Bright Prospects
by Shalu Saraf
Electronics - Semiconductors stocks are gaining from a robust demand environment for multi cloud-enabled software solutions.
Nasdaq's V-Bottom Signals Good Times: 5 Winners
by Tirthankar Chakraborty
There may be hiccups in one or two trading sessions but traditionally, the Nasdaq has given positive returns in the six- and 12-month period after the index completed a V-bottom since 1971.
Ambarella (AMBA) Catches Eye: Stock Jumps 6.5%
by Zacks Equity Research
Ambarella (AMBA) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Is AXT (AXTI) Stock a Solid Choice Right Now?
by Zacks Equity Research
AXT (AXTI) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
AXT, Inc. (AXTI) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in AXT, Inc. (AXTI).
The Zacks Analyst Blog Highlights: Osisko Gold Royalties, Chewy, VeriSign, AXT and Universal Technical Institute
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Osisko Gold Royalties, Chewy, VeriSign, AXT and Universal Technical Institute
Should You "Sell in May" or Buy 5 Top Coronavirus-Immune Stocks?
by Sanghamitra Saha
Many may be tempted by the "sell in May" adage this year. But policy easing and economic reopening should be gainful for these stocks that seem immune to coronavirus.
AXT, Clean Harbors, Walmart, Costco and Nike highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
AXT, Clean Harbors, Walmart, Costco and Nike highlighted as Zacks Bull and Bear of the Day